Apollo Medical Holdings Inc
NASDAQ:ASTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Apollo Medical Holdings Inc
NASDAQ:ASTH
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
|
Future Supply Chain Solutions Ltd
NSE:FSC
|
IN |
|
Tesoro Resources Ltd
ASX:TSO
|
AU |
Wall Street
Price Targets
ASTH Price Targets Summary
Apollo Medical Holdings Inc
According to Wall Street analysts, the average 1-year price target for
ASTH
is 36.72 USD
with a low forecast of 26.26 USD and a high forecast of 52.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ASTH's stock price target?
Price Target
36.72
USD
According to Wall Street analysts, the average 1-year price target for
ASTH
is 36.72 USD
with a low forecast of 26.26 USD and a high forecast of 52.5 USD.
What is Apollo Medical Holdings Inc's Revenue forecast?
Projected CAGR
14%
For the last 4 years the
compound annual growth rate for
Apollo Medical Holdings Inc's revenue is
42%.
The projected
CAGR
for the next 3 years is
14%.
What is Apollo Medical Holdings Inc's Operating Income forecast?
Projected CAGR
37%
For the last 4 years the
compound annual growth rate for
Apollo Medical Holdings Inc's operating income is
0%.
The projected
CAGR
for the next 3 years is
37%.
What is Apollo Medical Holdings Inc's Net Income forecast?
Projected CAGR
105%
For the last 4 years the
compound annual growth rate for
Apollo Medical Holdings Inc's net income is
-24%.
The projected
CAGR
for the next 2 years is
105%.
